drugset

drugset / Trial / NCT04987944

Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

NCT04987944 ↗

Phase 1 Terminated 45 enrolled Pfizer

RandomizedSequentialSingle-blindTreatment

Summary

This study is a double-blind, parallel-group, randomized study of active drug vs placebo in asthma.

Timeline

Start: 2021-10-18
Primary completion: 2023-03-29
Completion: 2023-04-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zavegepant	Small molecule	150 mg	Oral

Indications